Home | Contact Us | Search | Site Map
Crucell
STAR® Technology




Key Strengths
  • Established mammalian cell banks for protein and antibody production are the starting point for STAR® technology, thus specially engineered mammalian cells are not needed.

 

  • The STAR® technology allows for very rapid stable mammalian cell clone generation.

 

  • The STAR® technology typically yields stable mammalian cell clones that produce 5 to 10 fold higher antibody or other therapeutic proteins as compared to cell clones generated without STAR® technology. 
MoveNext - Latus © Crucell 2006 | Disclaimer